contraindications of glp 1 agonist Contraindications, warnings, and precautions GLP-1 receptor Non-insulin injectable antidiabetic drugs -

More Powerful Glycemic Control Both tirzepatide and retatrutide significantly improve blood sugar control

Following the approval of exenatide to treat type 2 diabetes (USA: 2005

GLP-1RAs significantly increased occurrence of diarrhea (OR: 2.18), hypoglycemia (OR: 3.10), vomiting (OR: 8.22), and nausea (OR: 4.41)

Two studies in our review utilized data with at least 95% collected prior to the ASA's initial recommendation: (i) Alkabbani et al covered the period from January 2015 to August 2023

69: 11351143 [DOI] [PubMed] [Google Scholar] 114.Creutzfeldt W, Ebert R, Willms B, et al

Even a modest 610% weight reduction can significantly improve IIH outcomes [5]